Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Antibiotics for Anal Abscess (OFF)
NCT03643198Recruiting
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Mar 2022
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ciprofloxacin and metronidazole in anal abscess (2 arms), sponsored by Hospital Universitari Germans Trias i Pujol. Primary endpoint: Perianal fistula incidence at 12 months. Started Mar 2022; status: recruiting.
02
Drugs
ciprofloxacinmetronidazole
03
Conditions
anal abscess
Beyond the preview
Go deeper on NCT03643198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03643198.